A case of complete response following the administration of pembrolizumab and metastasectomy for lung and bone metastases of bladder cancer.

Nakasato, Takehiko; Inoue, Tatsuki; Kato, Ryosuke; Nakagami, Yoshihiro; Oshinomi, Kazuhiko; Maeda, Yoshiko; Morita, Jun; Shichijo, Takeshi; Yamochi, Toshiko; Fukagai, Takashi

Nakasato, Takehiko; Inoue, Tatsuki; Kato, Ryosuke; Nakagami, Yoshihiro; Oshinomi, Kazuhiko; Maeda, Yoshiko; Morita, Jun; Shichijo, Takeshi; Yamochi, Toshiko; Fukagai, Takashi.

Afiliación

Nakasato T; Departments of Urology Showa University School of Medicine Tokyo Japan.
Inoue T; Departments of Urology Showa University School of Medicine Tokyo Japan.
Kato R; Departments of Urology Showa University School of Medicine Tokyo Japan.
Nakagami Y; Departments of Urology Showa University School of Medicine Tokyo Japan.
Oshinomi K; Departments of Urology Showa University School of Medicine Tokyo Japan.
Maeda Y; Departments of Urology Showa University School of Medicine Tokyo Japan.
Morita J; Departments of Urology Showa University School of Medicine Tokyo Japan.
Shichijo T; Departments of Urology Showa University School of Medicine Tokyo Japan.
Yamochi T; Pathology Showa University School of Medicine Tokyo Japan.
Fukagai T; Departments of Urology Showa University School of Medicine Tokyo Japan.

IJU Case Rep ; 5(2): 92-94, 2022 Mar.

Article en En | MEDLINE | ID: mdl-35252787

Palabras clave

bladder cancer; complete response; metastasectomy; pembrolizumab; urothelial cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: IJU Case Rep Año: 2022 Tipo del documento: Article Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google